182 related articles for article (PubMed ID: 11988408)
21. Hormonal contraceptive use and breast cancer in Thai women.
Poosari A; Promthet S; Kamsa-ard S; Suwanrungruang K; Longkul J; Wiangnon S
J Epidemiol; 2014; 24(3):216-20. PubMed ID: 24614914
[TBL] [Abstract][Full Text] [Related]
22. Contraceptive patterns of religious and racial groups in the United States, 1955-76: convergence and distinctiveness.
Mosher WD; Goldscheider C
Stud Fam Plann; 1984; 15(3):101-11. PubMed ID: 6740727
[TBL] [Abstract][Full Text] [Related]
23. Risk of breast cancer associated with short-term use of oral contraceptives.
Folger SG; Marchbanks PA; McDonald JA; Bernstein L; Ursin G; Berlin JA; Daling JR; Norman SA; Strom BL; Weiss LK; Simon MS; Burkman RT; Malone KE; Spirtas R
Cancer Causes Control; 2007 Mar; 18(2):189-98. PubMed ID: 17216547
[TBL] [Abstract][Full Text] [Related]
24. Breast cancer risk estimates for relatives of white and African American women with breast cancer in the Women's Contraceptive and Reproductive Experiences Study.
Simon MS; Korczak JF; Yee CL; Malone KE; Ursin G; Bernstein L; McDonald JA; Deapen D; Strom BL; Press MF; Marchbanks PA; Burkman RT; Weiss LK; Schwartz AG
J Clin Oncol; 2006 Jun; 24(16):2498-504. PubMed ID: 16735703
[TBL] [Abstract][Full Text] [Related]
25. Oral contraceptives in relation to breast cancer.
Malone KE; Daling JR; Weiss NS
Epidemiol Rev; 1993; 15(1):80-97. PubMed ID: 8405215
[TBL] [Abstract][Full Text] [Related]
26. Breast carcinoma etiology: current knowledge and new insights into the effects of reproductive and hormonal risk factors in black and white populations.
Pathak DR; Osuch JR; He J
Cancer; 2000 Mar; 88(5 Suppl):1230-8. PubMed ID: 10705360
[TBL] [Abstract][Full Text] [Related]
27. Oral contraceptives and breast cancer: final report of an epidemiological study.
Vessey M; Baron J; Doll R; McPherson K; Yeates D
Br J Cancer; 1983 Apr; 47(4):455-62. PubMed ID: 6849791
[TBL] [Abstract][Full Text] [Related]
28. A case control study of breast cancer risk and exposure to injectable progestogen contraceptives. Methods and patterns of use among controls.
Bailie R; Katzenellenbogen J; Hoffman M; Schierhout G; Truter H; Dent D; Gudgeon A; van Zyl J; Rosenberg L; Shapiro S
S Afr Med J; 1997 Mar; 87(3):302-5. PubMed ID: 9137342
[TBL] [Abstract][Full Text] [Related]
29. Breast cancer risk factors among black women and white women: similarities and differences.
Mayberry RM; Stoddard-Wright C
Am J Epidemiol; 1992 Dec; 136(12):1445-56. PubMed ID: 1288274
[TBL] [Abstract][Full Text] [Related]
30. Oral contraceptive use and breast cancer: a prospective study of young women.
Hunter DJ; Colditz GA; Hankinson SE; Malspeis S; Spiegelman D; Chen W; Stampfer MJ; Willett WC
Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2496-502. PubMed ID: 20802021
[TBL] [Abstract][Full Text] [Related]
31. Oral contraceptives, postmenopausal hormones, and risk of asynchronous bilateral breast cancer: the WECARE Study Group.
Figueiredo JC; Bernstein L; Capanu M; Malone KE; Lynch CF; Anton-Culver H; Stovall M; Bertelsen L; Haile RW; Bernstein JL;
J Clin Oncol; 2008 Mar; 26(9):1411-8. PubMed ID: 18250348
[TBL] [Abstract][Full Text] [Related]
32. Agreement between oral contraceptive users and prescribers: implications for case-control studies.
van Leeuwen FE; van Duijn CM; Camps MH; Kempers BA; Mentjens MF; Mulder HB; Schouten EG; Zwijsen RM; Rookus MA
Contraception; 1992 May; 45(5):399-408. PubMed ID: 1623713
[TBL] [Abstract][Full Text] [Related]
33. Effect of reproductive factors and oral contraceptives on breast cancer risk in BRCA1/2 mutation carriers and noncarriers: results from a population-based study.
Lee E; Ma H; McKean-Cowdin R; Van Den Berg D; Bernstein L; Henderson BE; Ursin G
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3170-8. PubMed ID: 18990759
[TBL] [Abstract][Full Text] [Related]
34. Injectable and oral contraceptive use and cancers of the breast, cervix, ovary, and endometrium in black South African women: case-control study.
Urban M; Banks E; Egger S; Canfell K; O'Connell D; Beral V; Sitas F
PLoS Med; 2012; 9(3):e1001182. PubMed ID: 22412354
[TBL] [Abstract][Full Text] [Related]
35. Exogenous progestins and breast cancer.
Stanford JL; Thomas DB
Epidemiol Rev; 1993; 15(1):98-107. PubMed ID: 8405216
[TBL] [Abstract][Full Text] [Related]
36. Use of low-dose oral contraceptives and stroke in young women.
Schwartz SM; Siscovick DS; Longstreth WT; Psaty BM; Beverly RK; Raghunathan TE; Lin D; Koepsell TD
Ann Intern Med; 1997 Oct; 127(8 Pt 1):596-603. PubMed ID: 9341057
[TBL] [Abstract][Full Text] [Related]
37. Absence of an effect of injectable and implantable progestin-only contraceptives on subsequent risk of breast cancer.
Strom BL; Berlin JA; Weber AL; Norman SA; Bernstein L; Burkman RT; Daling JR; Deapen D; Folger SG; Malone KE; Marchbanks PA; Simon MS; Ursin G; Weiss LK; Spirtas R
Contraception; 2004 May; 69(5):353-60. PubMed ID: 15105056
[TBL] [Abstract][Full Text] [Related]
38. Association between contemporary hormonal contraception and ovarian cancer in women of reproductive age in Denmark: prospective, nationwide cohort study.
Iversen L; Fielding S; Lidegaard Ø; Mørch LS; Skovlund CW; Hannaford PC
BMJ; 2018 Sep; 362():k3609. PubMed ID: 30257920
[TBL] [Abstract][Full Text] [Related]
39. Benign breast tumor and estrogenic hormones: a population-based retrospective study.
Nomura A; Comstock GW
Am J Epidemiol; 1976 May; 103(5):439-44. PubMed ID: 179318
[TBL] [Abstract][Full Text] [Related]
40. A cohort study of oral contraceptive use and risk of benign breast disease.
Rohan TE; Miller AB
Int J Cancer; 1999 Jul; 82(2):191-6. PubMed ID: 10389751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
